Join the Melanoma group to help and get support from people like you.
Melanoma News (Page 2)
Related terms: Cancer, Melanoma, Malignant Melanoma, Skin Cancer, Melanoma
Efficacy Shown for New Melanoma Therapeutic Vaccine
FRIDAY, Dec. 15, 2023 – In a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly skin...
New Melanoma Treatment Vaccine Shows Promise in Trial
FRIDAY, Dec. 15, 2023 – A new melanoma vaccine has shown its mettle in battling the deadly skin cancer in a new trial. People with advanced melanomas who received the vaccine plus Merck's cancer...
AI Accurate in Diagnosing Suspicious Skin Lesions
WEDNESDAY, Nov. 29, 2023 – A mobile phone-powered artificial intelligence (AI) technology is effective for diagnosing suspicious skin lesions, according to a study published in the October issue...
Occupational Exposure to Solar UVR Linked to Nonmelanoma Skin Cancer
MONDAY, Nov. 20, 2023 – Occupational exposure to solar ultraviolet radiation (UVR) is associated with a substantial burden of nonmelanoma skin cancer (NMSC), according to a study published in the...
UN Report Warns That Working in the Sun Causes Skin Cancers
THURSDAY, Nov. 9, 2023 (Healthday News) – New data from two United Nations agencies shows that millions of workers toiling under the sun's glare is fueling skin cancer cases around the world. Nearly...
AI Getting Better at Detecting Skin Cancer
FRIDAY, Nov. 3, 2023 – Artificial intelligence (AI) is increasingly accurate in detecting skin cancer, according to a study presented at the annual meeting of the European Academy of Dermatology and...
FDA Approves Nivolumab as Adjuvant Treatment for Melanoma
WEDNESDAY, Oct. 18, 2023 – The U.S. Food and Drug Administration has approved Opdivo (nivolumab) for the adjuvant treatment of completely resected stage IIB/C melanoma in patients ages 12 years and...
U.S. Food and Drug Administration Approves Opdivo (nivolumab) as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma
In the Phase 3 CheckMate -76K trial, Opdivo demonstrated a statistically significant improvement in recurrence-free survival compared to placebo1 CheckMate -76K marks the fifth Opdivo-based...
Latest AI Has 100% Success Rate in Spotting Melanomas
FRIDAY, Oct. 13, 2023 – The ability to detect skin cancer using artificial intelligence (AI) software has rapidly improved. New research presented Wednesday at a medical conference in Berlin shows...
Jimmy Carter 'Happy' in At-Home Hospice Care as 99th Birthday Nears
FRIDAY, Sept. 29, 2023 – Former President Jimmy Carter turned quite a few heads last week when he made a surprise visit to the Plains Peanut Festival in Georgia. Carter, who turns 99 on Sunday,...
Increased Exposure to PFAS, Phenols Linked to Prior Cancer Diagnosis
MONDAY, Sept. 25, 2023 – Per- and polyfluoroalkyl substances (PFAS), phenols, and parabens are associated with a previous cancer diagnosis, according to a study published online Sept. 18 in the...
Common PFAS Chemicals Linked to Cancers in Women
TUESDAY, Sept. 19, 2023 – Harmful "forever" chemicals are widespread in the environment, and new research hints they pose a particular health risk to women. A new study suggests women who are...
Former 'Real Housewife' Teddi Mellencamp Reveals Another Melanoma Diagnosis
THURSDAY, Sept. 14, 2023 – Reality TV star and wellness coach Teddi Mellencamp announced on Instagram Wednesday that she has been diagnosed with yet another melanoma. This is Mellencamp’s 12th or 1...
In Situ, Invasive Melanoma Diagnoses Decreased in 2020
THURSDAY, Sept. 7, 2023 – During 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 in JAMA Dermatology. Daniel Y....
Reinforced Learning Model Can Improve Sensitivity of Skin Cancer Diagnosis
WEDNESDAY, Aug. 9, 2023 – Incorporating human preferences into an image-based diagnostic algorithm can improve artificial intelligence (AI)-based decision support, according to a study published...
Ask a question
To post your own question to this support group, sign in or create an account.